To meet the growing demand for rapid, high-throughput screening of antibody candidates during antibody drug development, Quintara has launched the  HTP Recombinant Antibody Service. Our high-throughput platform can deliver a range of purified antibody products—including IgGs, Fab, scFv, VHH, di-scFv from micrograms to milligrams. This service enables fast and small-scale antibody expression, with production in as fast as 2 weeks. 

Powered by our self-developed high-throughput recombinant antibody expression platform, the system supports a capacity of up to 1,000 projects per month. The service is based on a mammalian cell expression system and utilizes our proprietary high-expression vector, which is transfected into CHO or HEK293 cells for efficient recombinant antibody production. 

Final delivery includes recombinant antibodies with >95% purity, and customizable specifications for HPLC purity, endotoxin levels, and concentration—tailored to suit your downstream application needs.

At Quintara, our antibody expression workflow is meticulously optimized to deliver high-quality, sequence-verified recombinant antibodies with exceptional speed and reliability.